271980 — Jeil Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩254bn
- KR₩301bn
- KR₩726bn
- 47
- 34
- 34
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -10,585 | 6,965 | -14,986 | -15,009 | 5,201 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 16,373 | 12,765 | 14,760 | 6,980 | 5,897 |
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 15,563 | -47,769 | 10,194 | -16,004 | -25,846 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 28,958 | -19,046 | 19,100 | -15,147 | -4,981 |
Capital Expenditures | -1,396 | -2,867 | -5,393 | -16,958 | -9,576 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 250 | -2,710 | -2,645 | 4,034 | -2,343 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,146 | -5,577 | -8,037 | -12,924 | -11,919 |
Financing Cash Flow Items | — | 38 | 27,498 | 26,001 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -16,589 | 15,133 | 11,069 | 33,618 | 18,766 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11,020 | -9,622 | 22,070 | 5,483 | 1,545 |